221 related articles for article (PubMed ID: 15855821)
1. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study.
Kamisawa T; Yoshiike M; Egawa N; Nakajima H; Tsuruta K; Okamoto A
Pancreatology; 2005; 5(2-3):234-8; discussion 238-40. PubMed ID: 15855821
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term outcomes of autoimmune pancreatitis.
Takuma K; Kamisawa T; Tabata T; Inaba Y; Egawa N; Igarashi Y
Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):146-52. PubMed ID: 21287714
[TBL] [Abstract][Full Text] [Related]
3. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
Ito T; Nakamura T; Fujimori N; Niina Y; Igarashi H; Oono T; Uchida M; Kawabe K; Takayanagi R; Nishimori I; Otsuki M; Shimosegawa T
J Dig Dis; 2011 Jun; 12(3):210-6. PubMed ID: 21615876
[TBL] [Abstract][Full Text] [Related]
6. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
[TBL] [Abstract][Full Text] [Related]
7. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
8. The natural course of autoimmune pancreatitis.
Kamisawa T; Anjiki H; Takuma K; Egawa N; Kubota N
Hepatogastroenterology; 2009; 56(91-92):866-70. PubMed ID: 19621719
[TBL] [Abstract][Full Text] [Related]
9. Exocrine and endocrine pancreatic function in 21 patients suffering from autoimmune pancreatitis before and after steroid treatment.
Frulloni L; Scattolini C; Katsotourchi AM; Amodio A; Gabbrielli A; Zamboni G; Benini L; Vantini I
Pancreatology; 2010; 10(2-3):129-33. PubMed ID: 20460944
[TBL] [Abstract][Full Text] [Related]
10. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.
Nishimori I; Tamakoshi A; Kawa S; Tanaka S; Takeuchi K; Kamisawa T; Saisho H; Hirano K; Okamura K; Yanagawa N; Otsuki M;
Pancreas; 2006 Apr; 32(3):244-8. PubMed ID: 16628078
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
Nishimori I; Otsuki M
Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy.
Agrawal S; Daruwala C; Khurana J
Ann Surg; 2012 Feb; 255(2):248-58. PubMed ID: 21997803
[TBL] [Abstract][Full Text] [Related]
15. Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study.
Ryu JK; Chung JB; Park SW; Lee JK; Lee KT; Lee WJ; Moon JH; Cho KB; Kang DW; Hwang JH; Yoo KS; Yoo BM; Lee DH; Kim HK; Moon YS; Lee J; Lee HS; Choi HS; Lee SK; Kim YT; Kim CD; Kim SJ; Hahm JS; Yoon YB
Pancreas; 2008 Nov; 37(4):377-85. PubMed ID: 18953249
[TBL] [Abstract][Full Text] [Related]
16. Management strategies for autoimmune pancreatitis.
Kamisawa T; Takuma K; Hara S; Tabata T; Kuruma S; Inaba Y; Gopalakrishna R; Egawa N; Itokawa F; Itoi T
Expert Opin Pharmacother; 2011 Oct; 12(14):2149-59. PubMed ID: 21711086
[TBL] [Abstract][Full Text] [Related]
17. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
18. Biliary tract involvement in autoimmune pancreatitis.
Nishino T; Toki F; Oyama H; Oi I; Kobayashi M; Takasaki K; Shiratori K
Pancreas; 2005 Jan; 30(1):76-82. PubMed ID: 15632703
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and indications for steroid therapy of sclerosing cholangitis associated with autoimmune pancreatitis.
Nakazawa T; Ohara H; Ando T; Hayashi K; Naitoh I; Okumura F; Tanaka H; Sano H; Joh T
Hepatogastroenterology; 2009; 56(91-92):584-8. PubMed ID: 19621659
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment.
Hirano K; Tada M; Isayama H; Yagioka H; Sasaki T; Kogure H; Nakai Y; Sasahira N; Tsujino T; Yoshida H; Kawabe T; Omata M
Gut; 2007 Dec; 56(12):1719-24. PubMed ID: 17525092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]